Not checkedNot checked for notices yet.
Advanced non-small cell lung cancer in patients aged 45 years or younger: outcomes and prognostic factors
Hsu Chia-Lin, Chen Kuan-Yu, Shih Jin-Yuan and 4 more
BMC Cancer · 2012
doi:10.1186/1471-2407-12-241 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
<p>Abstract</p> <p>Background</p> <p>Lung cancer in young patients (less or equal to 45 years) is uncommon and has clinical characteristics different from that in older patients. We investigated the outcomes and prognostic factors of young patients with advanced non-small cell lung cancer (NSCLC).</p> <p>Methods</p> <p>From January 2000 to December 2009, we enrolled patients aged ≤45 years and diagnosed with stage IIIB or IV NSCLC. Their clinical data, including age, gender, performance status, histologic types, disease stages, laboratory data at diagnosis, treatment modalities, and survival were reviewed and analyzed. A Cox proportional hazard model was used to calculate the hazard ratio (HR) and its 95% confidence interval (CI).</p> <p>Results</p> <p>A total of 144 patients with advanced NSCLC were included. Female patients were more prevalent (n = 74, 51.4%). Adenocarcinoma was the most common histologic type (n = 119, 82.6%) in both genders (male, n = 54, 77.1%; female, n = 65, 87.8%). Epidermal growth factor receptor (<it>EGFR)</it> sequences were determined using tumor specimens from 58 patients, and 29 showed an <it>EGFR</it> mutation. No significant difference in median survival was found between patient groups with and without the <it>EGFR</it> mutation (798 vs. 708 days, <it>p</it> = 0.65). In multivariate analysis, male gender (HR, 1.70; 95% CI: 1.08-2.68), body mass index (BMI) less than 25 kg/m<sup>2</sup> (HR, 2.72; 95% CI: 1.39-5.30), stage IV disease (HR, 2.62; 95% CI: 1.50-4.57), and anemia (HR, 2.08; 95% CI: 1.15-3.77) were associated with a short survival time.</p> <p>Conclusions</p> <p>Low BMI, stage IV disease, anemia at diagnosis, and male gender were the negative prognostic factors for young patients with advanced NSCLC.</p>
Abstract licence: CC BY-NC-ND
References48
40 more references, whose wording the paper’s licence keeps private.
All 48 referencesCited by papers we hold1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.